Global Plasma Protease C1-inhibitor Treatment Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Plasma Protease C1-inhibitor Treatment

• 1.1 Definition of Plasma Protease C1-inhibitor Treatment
• 1.2 Plasma Protease C1-inhibitor Treatment Segment by Drug Class
  • 1.2.1 Global Plasma Protease C1-inhibitor Treatment Production Growth Rate Comparison by Drug Class (2014-2025)
  • 1.2.2 C1-inhibitors
  • 1.2.3 Kallikrein Inhibitor (Kalbitor)
  • 1.2.4 Selective Bradykinin B2 Receptor Antagonist (Firazyr)
• 1.3 Plasma Protease C1-inhibitor Treatment Segment by Applications
  • 1.3.1 Global Plasma Protease C1-inhibitor Treatment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Independent Pharmacies and Outlets
• 1.4 Global Plasma Protease C1-inhibitor Treatment Overall Market
  • 1.4.1 Global Plasma Protease C1-inhibitor Treatment Revenue (2014-2025)
  • 1.4.2 Global Plasma Protease C1-inhibitor Treatment Production (2014-2025)
  • 1.4.3 North America Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
  • 1.4.4 Europe Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
  • 1.4.5 China Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
  • 1.4.6 Japan Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)
  • 1.4.8 India Plasma Protease C1-inhibitor Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Plasma Protease C1-inhibitor Treatment
• 2.3 Manufacturing Process Analysis of Plasma Protease C1-inhibitor Treatment
• 2.4 Industry Chain Structure of Plasma Protease C1-inhibitor Treatment

3 Development and Manufacturing Plants Analysis of Plasma Protease C1-inhibitor Treatment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Plasma Protease C1-inhibitor Treatment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Plasma Protease C1-inhibitor Treatment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Plasma Protease C1-inhibitor Treatment Production and Capacity Analysis
• 4.2 Plasma Protease C1-inhibitor Treatment Revenue Analysis
• 4.3 Plasma Protease C1-inhibitor Treatment Price Analysis
• 4.4 Market Concentration Degree

5 Plasma Protease C1-inhibitor Treatment Regional Market Analysis

• 5.1 Plasma Protease C1-inhibitor Treatment Production by Regions
  • 5.1.1 Global Plasma Protease C1-inhibitor Treatment Production by Regions
  • 5.1.2 Global Plasma Protease C1-inhibitor Treatment Revenue by Regions
• 5.2 Plasma Protease C1-inhibitor Treatment Consumption by Regions
• 5.3 North America Plasma Protease C1-inhibitor Treatment Market Analysis
  • 5.3.1 North America Plasma Protease C1-inhibitor Treatment Production
  • 5.3.2 North America Plasma Protease C1-inhibitor Treatment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Plasma Protease C1-inhibitor Treatment Import and Export
• 5.4 Europe Plasma Protease C1-inhibitor Treatment Market Analysis
  • 5.4.1 Europe Plasma Protease C1-inhibitor Treatment Production
  • 5.4.2 Europe Plasma Protease C1-inhibitor Treatment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Plasma Protease C1-inhibitor Treatment Import and Export
• 5.5 China Plasma Protease C1-inhibitor Treatment Market Analysis
  • 5.5.1 China Plasma Protease C1-inhibitor Treatment Production
  • 5.5.2 China Plasma Protease C1-inhibitor Treatment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Plasma Protease C1-inhibitor Treatment Import and Export
• 5.6 Japan Plasma Protease C1-inhibitor Treatment Market Analysis
  • 5.6.1 Japan Plasma Protease C1-inhibitor Treatment Production
  • 5.6.2 Japan Plasma Protease C1-inhibitor Treatment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Plasma Protease C1-inhibitor Treatment Import and Export
• 5.7 Southeast Asia Plasma Protease C1-inhibitor Treatment Market Analysis
  • 5.7.1 Southeast Asia Plasma Protease C1-inhibitor Treatment Production
  • 5.7.2 Southeast Asia Plasma Protease C1-inhibitor Treatment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Plasma Protease C1-inhibitor Treatment Import and Export
• 5.8 India Plasma Protease C1-inhibitor Treatment Market Analysis
  • 5.8.1 India Plasma Protease C1-inhibitor Treatment Production
  • 5.8.2 India Plasma Protease C1-inhibitor Treatment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Plasma Protease C1-inhibitor Treatment Import and Export

6 Plasma Protease C1-inhibitor Treatment Segment Market Analysis (by Type)

• 6.1 Global Plasma Protease C1-inhibitor Treatment Production by Type
• 6.2 Global Plasma Protease C1-inhibitor Treatment Revenue by Type
• 6.3 Plasma Protease C1-inhibitor Treatment Price by Type

7 Plasma Protease C1-inhibitor Treatment Segment Market Analysis (by Application)

• 7.1 Global Plasma Protease C1-inhibitor Treatment Consumption by Application
• 7.2 Global Plasma Protease C1-inhibitor Treatment Consumption Market Share by Application (2014-2019)

8 Plasma Protease C1-inhibitor Treatment Major Manufacturers Analysis

• 8.1 Shire plc
  • 8.1.1 Shire plc Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
  • 8.1.2 Shire plc Product Introduction, Application and Specification
  • 8.1.3 Shire plc Plasma Protease C1-inhibitor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 CSL Limited
  • 8.2.1 CSL Limited Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
  • 8.2.2 CSL Limited Product Introduction, Application and Specification
  • 8.2.3 CSL Limited Plasma Protease C1-inhibitor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Sanquin
  • 8.3.1 Sanquin Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
  • 8.3.2 Sanquin Product Introduction, Application and Specification
  • 8.3.3 Sanquin Plasma Protease C1-inhibitor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Pharming Group N.V.
  • 8.4.1 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Production Sites and Area Served
  • 8.4.2 Pharming Group N.V. Product Introduction, Application and Specification
  • 8.4.3 Pharming Group N.V. Plasma Protease C1-inhibitor Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served

9 Development Trend of Analysis of Plasma Protease C1-inhibitor Treatment Market

• 9.1 Global Plasma Protease C1-inhibitor Treatment Market Trend Analysis
  • 9.1.1 Global Plasma Protease C1-inhibitor Treatment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Plasma Protease C1-inhibitor Treatment Regional Market Trend
  • 9.2.1 North America Plasma Protease C1-inhibitor Treatment Forecast 2019-2025
  • 9.2.2 Europe Plasma Protease C1-inhibitor Treatment Forecast 2019-2025
  • 9.2.3 China Plasma Protease C1-inhibitor Treatment Forecast 2019-2025
  • 9.2.4 Japan Plasma Protease C1-inhibitor Treatment Forecast 2019-2025
  • 9.2.5 Southeast Asia Plasma Protease C1-inhibitor Treatment Forecast 2019-2025
  • 9.2.6 India Plasma Protease C1-inhibitor Treatment Forecast 2019-2025
• 9.3 Plasma Protease C1-inhibitor Treatment Market Trend (Product Type)
• 9.4 Plasma Protease C1-inhibitor Treatment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Plasma Protease C1-inhibitor Treatment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List